Loading…
A vote for robustness: Monitoring serum enzyme activity by thin-layer chromatography of dabsylated bradykinin products
•Robust TLC-based assay for monitoring of peptide cleavage by serum proteases.•Lowered concentrations of dabsylated bradykinin fragment 1–5 are associated with reduced ACE-activity.•Very little patient material (3μL serum) is required.•Simple protocol, no high-end equipment. High-end analytical meth...
Saved in:
Published in: | Journal of pharmaceutical and biomedical analysis 2017-09, Vol.143, p.199-203 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •Robust TLC-based assay for monitoring of peptide cleavage by serum proteases.•Lowered concentrations of dabsylated bradykinin fragment 1–5 are associated with reduced ACE-activity.•Very little patient material (3μL serum) is required.•Simple protocol, no high-end equipment.
High-end analytical methods provide excellent data but may lack the robustness required in large analytical studies. In particular complex chemical matrices may cause difficulties and increase the need for extensive sample preparation. For screening of patients we thus developed a low-tech assay to monitor bradykinin degradation by serum proteases. The bradykinin concentration mirrors the activity of angiotensin-converting enzyme (ACE). Dabsylated bradykinin (DBK) and its labeled fragments DBK1-8 and DBK1-5 were visualized by thin-layer chromatography using only 3μL of serum. Lower DBK1-5 levels indicated reduced ACE activity due to medication (ACE-inhibitors) or disease. Provided that purified DBK is available, the assay protocol itself is very simple and does not require any expensive high-end equipment. |
---|---|
ISSN: | 0731-7085 1873-264X |
DOI: | 10.1016/j.jpba.2017.06.007 |